Results 91 to 100 of about 2,071 (176)

Exploring bimekizumab for psoriasis treatment: Multicenter perspectives from Canada - Supplementary Materials

Supplementary Materials for manuscript Exploring bimekizumab for psoriasis treatment: Multicenter perspectives from Canada by Lovegrove et ...
Lovegrove, Fiona
core   +1 more source

Comparative Efficacy of Interleukin Inhibitors and JAK Inhibitors in Moderate to Severe Plaque Psoriasis. [PDF]

Cureus
Daily A, Danchulis L, Krulikowski K, Shectman B, Riskin SI.   +4 more
europepmc   +1 more source

IL-17 ligand-targeting inhibitors in psoriatic arthritis: a focused systematic review and network meta-analysis of efficacy, safety, and certainty of evidence. [PDF]

Front Immunol
AbuJwaid YK, Assi AK, Amro AM, Awwad HH, Ehmidat M, Deeb S, Awlad Mohammad MW, Dwayat A, Odeh A, Albow Y, Yasini M, Alfrookh M, Alamlih L.   +12 more
europepmc   +1 more source

Early and significant improvement of rupioid psoriasis with bimekizumab. [PDF]

Postepy Dermatol Alergol
Kurmuş GI, Yılmaz EB, Kartal SP, Alper M.   +3 more
europepmc   +1 more source

Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review

Bimekizumab is the most recent interleukin (IL)-17 inhibitors (IL-17i) approved for plaque psoriasis in adult patients. Despite biologic switching being common in routine clinical practice, evidence remains sparse regarding switching within class from ...
Sood, Siddhartha
core   +1 more source

Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study. [PDF]

Biomedicines
Pinto-Tasende JA, Garcia-Porrua C, Maceiras-Pan F, Melero-González RB, Hernandez Del Rio A, Cervantes Pérez EC, Quevedo-Vila V, Iñiguez CL, Alonso-Castro S, Caeiro-Aguado M, Queiro R.   +10 more
europepmc   +1 more source

Case Report: Successful Treatment of Refractory SAPHO Syndrome With Bimekizumab. [PDF]

Int J Rheum Dis
Martínez Calabuig P, Peñuelas Leal R, Fragío Gil JJ, González Mazarío R, Campos Fernández C.   +4 more
europepmc   +1 more source

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy. [PDF]

Dermatol Ther (Heidelb)
Fratton Z, Bighetti S, Bettolini L, Venturini M, Rossi M, Carugno A, Zerbinati N, Stinco G, Errichetti E.   +8 more
europepmc   +1 more source

Neuropathic Pain Management Using Novel Biologics in Moderate-to-Severe Hidradenitis Suppurativa. [PDF]

Curr Pain Headache Rep
Feeney JM, Henderson NA, Patel TM, Ardoin AK, Anwar AI, Abd-Elsayed A, Kaye AD.   +6 more
europepmc   +1 more source

Bimekizumab in refractory pityriasis rubra pilaris

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023
Christian Kromer, Michael P. Schön, Rotraut Mössner   +2 more
openaire   +3 more sources